Evaxion Property Plant And Equipment Net vs Total Assets Analysis

EVAX Stock  USD 1.17  0.02  1.68%   
Evaxion Biotech financial indicator trend analysis is much more than just examining Evaxion Biotech AS latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evaxion Biotech AS is a good investment. Please check the relationship between Evaxion Biotech Property Plant And Equipment Net and its Total Assets accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Property Plant And Equipment Net vs Total Assets

Property Plant And Equipment Net vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Evaxion Biotech AS Property Plant And Equipment Net account and Total Assets. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Evaxion Biotech's Property Plant And Equipment Net and Total Assets is -0.07. Overlapping area represents the amount of variation of Property Plant And Equipment Net that can explain the historical movement of Total Assets in the same time period over historical financial statements of Evaxion Biotech AS, assuming nothing else is changed. The correlation between historical values of Evaxion Biotech's Property Plant And Equipment Net and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Net of Evaxion Biotech AS are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Property Plant And Equipment Net i.e., Evaxion Biotech's Property Plant And Equipment Net and Total Assets go up and down completely randomly.

Correlation Coefficient

-0.07
Relationship DirectionNegative 
Relationship StrengthInsignificant

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Total Assets

Total assets refers to the total amount of Evaxion Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Evaxion Biotech AS books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Evaxion Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evaxion Biotech AS current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Issuance Of Capital Stock is likely to rise to about 15.2 M in 2024, whereas Tax Provision is likely to drop (825.3 K) in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization343.5K571.3K615.9K330.1K
Interest Income2.0M2.8M2.3M1.4M

Evaxion Biotech fundamental ratios Correlations

0.190.130.140.43-0.07-0.150.050.120.24-0.01-0.240.240.25-0.08-0.24-0.090.09-0.090.160.290.170.060.00.010.88
0.190.850.81-0.160.510.24-0.780.410.250.390.640.25-0.67-0.60.710.530.180.890.110.36-0.090.470.680.640.02
0.130.850.62-0.160.590.18-0.940.640.230.60.750.23-0.62-0.640.890.590.420.90.090.350.0-0.010.830.85-0.06
0.140.810.62-0.260.48-0.05-0.60.590.450.560.530.45-0.77-0.830.540.460.470.790.340.450.10.680.580.56-0.11
0.43-0.16-0.16-0.26-0.830.650.48-0.46-0.72-0.6-0.71-0.720.350.43-0.53-0.82-0.34-0.47-0.77-0.7-0.720.01-0.48-0.580.79
-0.070.510.590.48-0.83-0.51-0.810.710.760.790.930.76-0.44-0.60.781.00.470.740.720.790.67-0.090.860.86-0.49
-0.150.240.18-0.050.65-0.510.04-0.42-0.88-0.45-0.21-0.880.030.380.01-0.47-0.410.03-0.93-0.81-0.970.12-0.12-0.330.26
0.05-0.78-0.94-0.60.48-0.810.04-0.73-0.41-0.74-0.92-0.410.630.67-0.98-0.81-0.49-0.94-0.31-0.51-0.230.07-0.92-0.940.33
0.120.410.640.59-0.460.71-0.42-0.730.610.980.670.61-0.4-0.770.690.660.930.660.550.610.51-0.120.730.81-0.23
0.240.250.230.45-0.720.76-0.88-0.410.610.640.521.0-0.35-0.670.330.720.490.40.990.980.930.110.460.63-0.25
-0.010.390.60.56-0.60.79-0.45-0.740.980.640.730.64-0.38-0.720.730.740.910.680.60.630.56-0.130.730.81-0.38
-0.240.640.750.53-0.710.93-0.21-0.920.670.520.730.52-0.59-0.60.920.940.40.870.460.570.38-0.060.940.89-0.55
0.240.250.230.45-0.720.76-0.88-0.410.611.00.640.52-0.35-0.670.330.720.490.40.990.980.930.110.460.63-0.25
0.25-0.67-0.62-0.770.35-0.440.030.63-0.4-0.35-0.38-0.59-0.350.84-0.64-0.43-0.25-0.77-0.25-0.36-0.07-0.49-0.54-0.650.44
-0.08-0.6-0.64-0.830.43-0.60.380.67-0.77-0.67-0.72-0.6-0.670.84-0.62-0.55-0.66-0.75-0.58-0.66-0.43-0.35-0.62-0.790.28
-0.240.710.890.54-0.530.780.01-0.980.690.330.730.920.33-0.64-0.620.780.480.930.240.420.17-0.10.870.91-0.48
-0.090.530.590.46-0.821.0-0.47-0.810.660.720.740.940.72-0.43-0.550.780.40.740.690.760.63-0.090.870.84-0.49
0.090.180.420.47-0.340.47-0.41-0.490.930.490.910.40.49-0.25-0.660.480.40.450.460.470.44-0.130.430.59-0.2
-0.090.890.90.79-0.470.740.03-0.940.660.40.680.870.4-0.77-0.750.930.740.450.290.490.130.250.840.86-0.36
0.160.110.090.34-0.770.72-0.93-0.310.550.990.60.460.99-0.25-0.580.240.690.460.290.950.960.070.360.54-0.31
0.290.360.350.45-0.70.79-0.81-0.510.610.980.630.570.98-0.36-0.660.420.760.470.490.950.890.070.50.71-0.2
0.17-0.090.00.1-0.720.67-0.97-0.230.510.930.560.380.93-0.07-0.430.170.630.440.130.960.89-0.190.30.49-0.28
0.060.47-0.010.680.01-0.090.120.07-0.120.11-0.13-0.060.11-0.49-0.35-0.1-0.09-0.130.250.070.07-0.19-0.09-0.130.04
0.00.680.830.58-0.480.86-0.12-0.920.730.460.730.940.46-0.54-0.620.870.870.430.840.360.50.3-0.090.87-0.29
0.010.640.850.56-0.580.86-0.33-0.940.810.630.810.890.63-0.65-0.790.910.840.590.860.540.710.49-0.130.87-0.36
0.880.02-0.06-0.110.79-0.490.260.33-0.23-0.25-0.38-0.55-0.250.440.28-0.48-0.49-0.2-0.36-0.31-0.2-0.280.04-0.29-0.36
Click cells to compare fundamentals

Evaxion Biotech Account Relationship Matchups

Evaxion Biotech fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets11.1M12.0M40.2M(58.9M)12.9M13.5M
Short Long Term Debt Total36K20K3.7M2.3M10.9M11.4M
Other Current Liab1.0M1.2M1.0M1.2M3.9M4.1M
Total Current Liabilities1.7M4.9M4.3M3.8M7.1M5.0M
Total Stockholder Equity9.4M7.0M(50.4M)(72.7M)(4.7M)(5.0M)
Property Plant And Equipment Net126K457K5.4M4.7M4.3M2.4M
Net Debt(9.5M)(5.8M)(28.5M)(10.9M)5.3M5.6M
Retained Earnings(15.8M)(27.3M)(50.4M)(72.7M)(108.0M)(102.6M)
Accounts Payable646K3.7M2.8M2.1M2.7M1.9M
Cash9.6M5.8M32.2M13.2M5.6M5.3M
Non Current Assets Total126K6.1M5.5M5.0M4.5M3.4M
Cash And Short Term Investments9.6M5.8M32.2M13.2M5.6M5.3M
Net Receivables931K1.8M1.9M789K1.1M1.1M
Liabilities And Stockholders Equity11.1M12.0M(42.7M)(58.9M)12.9M13.5M
Non Current Liabilities Total682K2.7M3.4M10.0M10.5M11.1M
Capital Lease Obligations36K20K2.5M2.3M2.2M1.1M
Other Current Assets468.0K6.3M3.2M2.5M1.7M2.3M
Total Liab1.7M4.9M7.7M13.7M17.6M18.5M
Net Invested Capital9.4M7.0M33.6M16.3M3.9M3.7M
Total Current Assets11.0M5.8M34.7M14.0M8.4M13.3M
Accumulated Other Comprehensive Income22.7M31.7M79.1M(3.7M)(3.8M)(3.6M)
Net Working Capital9.2M6.0M30.4M13.2M1.3M1.2M
Short Term Debt36K40K440K439K485K460.8K
Common Stock2.5M2.6M3.8M3.9M5.9M3.6M
Other Assets25K694K191K(78.0M)134.0140.7
Inventory(6.0)(6.9M)(1.9M)(2.5M)(2.2M)(2.4M)
Other Stockholder Equity(169K)34.3M(82.9M)80.7M101.1M106.2M
Capital Stock2.5M2.6M3.8M3.9M5.9M3.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Evaxion Stock Analysis

When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.